New discoveries and innovative technologies will create growth
opportunities in the in-vitro diagnostics (IVD) market with
molecular diagnostic assays set to feature strongly in the
development of personalised medicine and theranostics.
Balchem reported a small rise in net sales, up 3 per cent overall
during the first quarter of 2003, but said it was pleased with
results in light of the continued difficult economic environment.
Net earnings at the New York-based...
